FOXC2 has been reported to be overexpressed in numerous cancers and function as a central regulator for epithelia-mesenchymal transition (EMT) and metastasis, including breast cancer, lung cancer, colorectal cancer, et al19-22. The gene discussed is FOXC2; the disease is colorectal cancer.